Epizyme to Present at the Jefferies 2017 London Healthcare Conference
CAMBRIDGE, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will present a company overview at the Jefferies 2017 London …